Atlas Venture Life Science Advisors

Latest statistics and disclosures from Atlas Venture Life Science Advisors's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are KYMR, IRON, DYN, THRD, DAWN, and represent 78.47% of Atlas Venture Life Science Advisors's stock portfolio.
  • Added to shares of these 1 stock: Korro Bio (+$54M).
  • Started 1 new stock position in Korro Bio.
  • Reduced shares in these 1 stock: IRON (-$11M).
  • Atlas Venture Life Science Advisors was a net buyer of stock by $43M.
  • Atlas Venture Life Science Advisors has $840M in assets under management (AUM), dropping by 30.07%.
  • Central Index Key (CIK): 0001917529

Tip: Access up to 7 years of quarterly data

Positions held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors holds 16 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kymera Therapeutics Common Stock (KYMR) 17.8 $149M 5.9M 25.46
 View chart
Disc Medicine Common Stock (IRON) 17.6 $148M -6% 2.6M 57.76
 View chart
Dyne Therapeutics Common Stock (DYN) 15.7 $132M 9.9M 13.30
 View chart
Third Harmonic Bio Common Stock (THRD) 14.2 $120M 11M 10.97
 View chart
Day One Biopharmaceuticals Common Stock (DAWN) 13.2 $111M 7.6M 14.60
 View chart
Korro Bio Common Stock 6.4 $54M NEW 1.1M 47.93
 View chart
Aerovate Therapeutics Common Stock (AVTE) 5.5 $46M 2.0M 22.63
 View chart
Vigil Neuroscience Common Stock (VIGL) 2.3 $20M 5.8M 3.38
 View chart
Replimune Group Common Stock (REPL) 2.1 $18M 2.1M 8.43
 View chart
Generation Bio Common Stock (GBIO) 1.6 $14M 8.3M 1.65
 View chart
Ikena Oncology Common Stock (IKNA) 1.2 $9.9M 5.0M 1.97
 View chart
Akero Therapeutics Common Stock (AKRO) 1.0 $8.4M 359k 23.35
 View chart
AvroBio Common Stock (AVRO) 0.7 $6.2M 4.5M 1.36
 View chart
Dianthus Therapeutics Common Stock (DNTH) 0.3 $2.5M 237k 10.40
 View chart
Xilio Therapeutics Common Stock (XLO) 0.2 $1.5M 2.8M 0.55
 View chart
Spero Therapeutics Common Stock (SPRO) 0.2 $1.5M 1.0M 1.47
 View chart

Past Filings by Atlas Venture Life Science Advisors

SEC 13F filings are viewable for Atlas Venture Life Science Advisors going back to 2022